Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Ecgonine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002760 AN004485 Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) Kidney outer medulla Rat Medical College of Wisconsin Area
ST002283 AN003728 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire Area integration
ST001875 AN003037 Metabolomics analysis of multiple samples on AB 5600-Part 2 Feces Mouse Dalian Institute Of Chemical Physics blank-substracted abundances
ST001875 AN003037 Metabolomics analysis of multiple samples on AB 5600-Part 2 Liver Mouse Dalian Institute Of Chemical Physics blank-substracted abundances
ST001922 AN003123 Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages Macrophages Human MST-MedDesign, Discovery Analytical, GSK, Upper Providence, US counts
ST001922 AN003124 Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages Macrophages Human MST-MedDesign, Discovery Analytical, GSK, Upper Providence, US counts
ST000913 AN001483 Insights into the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through metabolomic profiling of cerebrospinal fluid (part IV) Cerebrospinal fluid Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, Davis Counts
ST002016 AN003284 Metabolomics of COVID patients Blood Human COVID-19 University of Virginia intensity
ST002775 AN004517 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Normalized Concentrations
ST002027 AN003297 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) Blood Human UC Davis normalized peak height
ST002028 AN003298 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) Feces Human UC Davis normalized peak height
ST002711 AN004393 Metabolomic analysis of maternal mid-gestation plasma and cord blood: biogenic amines Blood Human Autism Columbia University normalized peak heights
ST001873 AN003035 Metabolomics analysis of multiple samples on AB 5600-Part 1 Blood Human Dalian Institute Of Chemical Physics peak area
ST001873 AN003035 Metabolomics analysis of multiple samples on AB 5600-Part 1 Hep G2 cells Human Dalian Institute Of Chemical Physics peak area
ST001873 AN003035 Metabolomics analysis of multiple samples on AB 5600-Part 1 Urine Human Dalian Institute Of Chemical Physics peak area
ST001719 AN002802 Metabolomics Analysis of Philadelphia Cohort - Update (part-I) Blood Human HIV The Wistar Institute Peak area
ST001720 AN002803 Metabolomics Analysis of ACTG Cohort -Update (part-II) Blood Human HIV The Wistar Institute Peak area
ST002776 AN004519 Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Peak Area
ST001383 AN002306 Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children. Blood Human Environmental exposure University of Michigan Peak area normalized
ST000403 AN000643 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000414 AN000655 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000819 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST001211 AN002017 Metabolomic Markers of Methotrexate Response, In Vitro Cultured cells Human University Of Kansas Peak height
ST001928 AN003136 Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype Urine Human George Mason University Peak height
ST001815 AN002945 Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis Blood Human Arthritis University Of Kansas Peak Height Intensity
ST001949 AN003173 Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy Blood Human Rheumatoid arthritis University of Kansas Peak Height Intensity
ST001154 AN001944 A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium Blood Mouse University of California Peak height normalized with creatinine
ST000356 AN000583 GC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum data Blood Human Cancer University of Hawaii Cancer Center Peak intensity
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000667 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST001849 AN002993 Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) Blood Human COVID-19 Washington University, St. Louis Relative Intensity
ST001849 AN002994 Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) Blood Human COVID-19 Washington University, St. Louis Relative Intensity
  logo